France To Replace AstraZeneca Booster With mRNA Jab In Under-55s
Source : 'The Pink Sheet'
The French government says that people under the age of 55 years who have had their first injection with the Oxford/AstraZeneca PLC COVID-19 vaccine should be given an...
White House Reiterates Confidence In FDA Expertise, Independence With J&J Vaccine Pause
Source : 'The Pink Sheet'
White House and other officials affirmed their confidence in the US Food and Drug Administration and the Centers for Disease Control and Prevention after the agencies caused a stir by...
J&J COVID-19 Vaccine Pause Expected To Be Brief, But Subsequent Use May Be Restricted
Source : 'The Pink Sheet'
The US Centers for Disease Control and Prevention’s Advisory Committee on Immunization Practices will take the immediate next steps to determine what happens with Johnson & Johnson’s COVID-19...
PhRMA’s ‘Better Way:’ Remember COVID Success, Tweak Part B, And Bash HR 3
Source : 'The Pink Sheet'
The Pharmaceutical Researchers and Manufacturers of America new “Better Way” Agenda for the US health care system doesn’t offer much in the way of original policy ideas industry...
US FDA Oncology Center Wants Trial Datasets Flagged As Remote Or In-Person Assessments
Source : 'The Pink Sheet'
The US Food and Drug Administration's oncology center intends to leverage datasets from cancer studies interrupted by the COVID-19 pandemic to advance the use of decentralized clinical trial approaches.
The Oncology...